Atlas Trials

Stage IV Uterine Sarcoma

11 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Stage IV Uterine Sarcoma

RecordFirmDate
Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Patients With Primary or Recurrent Uterine, Endometrial, or Cervical Cancer (NCT01098630)Gynecologic Oncology Group2010-07-01
Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors (NCT01155258)University of Southern California2010-06-01
Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma (NCT01154452)National Cancer Institute (NCI)2010-06-01
Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery (NCT01553539)Wake Forest University Health Sciences2009-10-01
Stereotactic Radiosurgery Using CyberKnife in Treating Women With Advanced or Recurrent Gynecological Malignancies (NCT01079832)Case Comprehensive Cancer Center2009-05-01
Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma (NCT00390234)National Cancer Institute (NCI)2006-09-01
Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma (NCT00245102)National Cancer Institute (NCI)2005-09-01
Sorafenib in Treating Patients With Advanced or Recurrent Uterine Cancer (NCT00238121)National Cancer Institute (NCI)2005-02-01
EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer (NCT00087191)National Cancer Institute (NCI)2004-05-01
17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma (NCT00004241)National Cancer Institute (NCI)1999-10-01

Track Stage IV Uterine Sarcoma automatically

Every clearance here is in the API, with alerts when new ones post.